CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s filing signal turned negative.

Charles River Laboratories International, Inc. is a global, full-service, non-clinical drug development partner that supports clients from target identification through non-clinical development. Founded in 1947, the company has expanded from its core competency in research model technologies to offer a diverse portfolio of discovery and safety assessment services, alongside manufacturing support products and services. Operating in over 120 sites across more than 20 countries, Charles River serves a broad client base including major pharmaceutical and biotechnology companies, academic institutions, and government agencies. Its strategy focuses on delivering a comprehensive and integrated portfolio to accelerate biomedical research and therapeutic innovation, leveraging deep scientific expertise and a commitment to animal welfare.

Revenue is primarily driven by the provision of research models and related services, discovery and safety assessment services for drug development, and manufacturing support solutions including microbial and biologics testing.